UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen

Annals of oncology, 2007-01, Vol.18 (1), p.45-51

2007

Volltextzugriff (PDF)

Sequence of therapy and survival in patients with advanced pancreatic neuroendocrine tumours

Current oncology (Toronto), 2020-08, Vol.27 (4), p.215-219

2020

Volltextzugriff (PDF)

Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome

Annals of oncology, 2012-02, Vol.23 (2), p.338-345

2012

Volltextzugriff (PDF)

Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?

Annals of oncology, 2012-04, Vol.23 (4), p.876-881

2012

Volltextzugriff (PDF)

A retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada

Current oncology (Toronto), 2019-12, Vol.26 (6), p.e748-754

2019

Volltextzugriff (PDF)

Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic

Current oncology (Toronto), 2020-10, Vol.27 (5), p.e501-511

2020

Volltextzugriff (PDF)

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response

British journal of cancer, 2008-06, Vol.98 (11), p.1810-1819

2008

Volltextzugriff (PDF)

2002 Impact of adjuvant chemotherapy following pre-operative short course radiotherapy in stage II rectal cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S327-S328

2015

Volltextzugriff (PDF)

Prognostic effect of sidedness in early stage versus advanced colon cancer

Health science reports, 2018-08, Vol.1 (8), p.e54-n/a

2018

Volltextzugriff (PDF)

Factors associated with delayed time to adjuvant chemotherapy in stage iii colon cancer

Current oncology (Toronto), 2014-08, Vol.21 (4), p.181-186

2014

Volltextzugriff (PDF)

2132 Retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada

European journal of cancer (1990), 2015-09, Vol.51, p.S376-S376

2015

Volltextzugriff (PDF)

Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer

Current oncology (Toronto), 2016-10, Vol.23 (5), p.329-333

2016

Volltextzugriff (PDF)

Molecular Subtype Predicts Outcome in Nearly All Subsets of Women With Early-stage Invasive Breast Cancer Defined by Traditional Clinical and Pathological Prognostic Factors

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S140-S141

2012

Volltextzugriff (PDF)

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer

Current oncology (Toronto), 2013-12, Vol.20 (6), p.326-332

2013

Volltextzugriff (PDF)

Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group

Current oncology (Toronto), 2010-06, Vol.17 (3), p.49-64

2010

Volltextzugriff (PDF)

565P Neoadjuvant chemotherapy, excision, and observation for early rectal cancer: The phase II NEO trial (CCTG CO.28) results after minimum 3 years follow up

Annals of oncology, 2024-09, Vol.35, p.S462-S463

2024

Volltextzugriff (PDF)

Abstract No. 178: Pharmacokinetic release pattern of doxorubicin-loaded superabsorbent polymer microspheres: In vivo phase I dose escalation trial

Journal of vascular and interventional radiology, 2011, Vol.22 (3), p.S77-S77

2011

Volltextzugriff (PDF)

Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014

Current oncology (Toronto), 2015-04, Vol.22 (2), p.e113-123

2015

Volltextzugriff (PDF)

Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1–2pN0 disease?

Annals of oncology, 2010-05, Vol.21 (5), p.988-993

2010

Volltextzugriff (PDF)

528PDImpact of clonality and DNA repair mutations on plasma tumour mutation burden (pTMB) and immunotherapy efficacy in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) in CCTG CO.26

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Predictors of positive radial margin status in a population-based cohort of patients with rectal cancer

Current oncology (Toronto), 2008-04, Vol.15 (2), p.98-103

2008

Volltextzugriff (PDF)

217 Outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma: a population based study from British Columbia

European journal of cancer supplements, 2010, Vol.8 (3), p.122-122

2010

Volltextzugriff (PDF)

Extended adjuvant (EA) endocrine therapy – Tamoxifen (TAM) or an aromatase inhibitor (Al)?

European journal of cancer supplements, 2008, Vol.6 (7), p.114-114

2008

Volltextzugriff (PDF)

Effect of Resection of Metastasis (Rom) and All 3, 4 and 5 Active Agents in Metastatic Colorectal Cancer (Mcrc) Between 1995-2010

Annals of oncology, 2014-09, Vol.25, p.iv202

2014

Volltextzugriff (PDF)

593PEFFECT OF RESECTION OF METASTASIS (ROM) AND ALL 3, 4 AND 5 ACTIVE AGENTS IN METASTATIC COLORECTAL CANCER (MCRC) BETWEEN 1995-2010

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv202-iv203

2014

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(120)
magazinearticle
(2)

Sprache

Englisch
(118)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Oncology
(35)
Humans
(28)
Female
(21)
Middle Aged
(17)
Aged
(14)
Hematology, Oncology And Palliative Medicine
(13)
Tumors
(12)
Biological And Medical Sciences
(9)
Breast Neoplasms - Pathology
(9)
Medical Sciences
(9)
Prognosis
(9)
Adult
(8)
Gynecology. Andrology. Obstetrics
(8)
Male
(8)
Mammary Gland Diseases
(8)
Patients
(8)
Aged, 80 And Over
(7)
Chemotherapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen

Sequence of therapy and survival in patients with advanced pancreatic neuroendocrine tumours

Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome

Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?

A retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada

Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response

2002 Impact of adjuvant chemotherapy following pre-operative short course radiotherapy in stage II rectal cancer

Prognostic effect of sidedness in early stage versus advanced colon cancer

Factors associated with delayed time to adjuvant chemotherapy in stage iii colon cancer

2132 Retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada

Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer

Molecular Subtype Predicts Outcome in Nearly All Subsets of Women With Early-stage Invasive Breast Cancer Defined by Traditional Clinical and Pathological Prognostic Factors

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer

Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group

565P Neoadjuvant chemotherapy, excision, and observation for early rectal cancer: The phase II NEO trial (CCTG CO.28) results after minimum 3 years follow up

Abstract No. 178: Pharmacokinetic release pattern of doxorubicin-loaded superabsorbent polymer microspheres: In vivo phase I dose escalation trial

Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014

Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1–2pN0 disease?

528PDImpact of clonality and DNA repair mutations on plasma tumour mutation burden (pTMB) and immunotherapy efficacy in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) in CCTG CO.26

Predictors of positive radial margin status in a population-based cohort of patients with rectal cancer

217 Outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma: a population based study from British Columbia

Extended adjuvant (EA) endocrine therapy – Tamoxifen (TAM) or an aromatase inhibitor (Al)?

Effect of Resection of Metastasis (Rom) and All 3, 4 and 5 Active Agents in Metastatic Colorectal Cancer (Mcrc) Between 1995-2010

593PEFFECT OF RESECTION OF METASTASIS (ROM) AND ALL 3, 4 AND 5 ACTIVE AGENTS IN METASTATIC COLORECTAL CANCER (MCRC) BETWEEN 1995-2010

Suchergebnisse filtern